The government approval of Celebrex is a boost for Monsanto, which last summer had to drop plans to merge with American Home Products, maker of Robitussin cough syrup and Advil pain reliever.
But instead of also seeking indication for rheumatoid arthritis, which affects about 2 million Americans, it wants the FDA to approve Vioxx for acute pain treatment - a market of more than 40 million Americans.
They offer the same pain relief as traditional arthritis drugs but cause fewer side effects, especially ulcers and intestinal bleeding.
Many primary-care physicians are unaware of aggressive treatment strategies that go beyond medications, despite research showing the value of support groups, exercise classes and other complementary therapies.
The doctors are comparing 180 patients at the Veterans Affairs Medical Center divided into three groups.
One study shows that osteoarthritis has the potential to compromise the health of family members as a result of the patient's negative responses to symptoms and the burden of providing emotional support and task assistance to the patient.
A Tufts University study presented at the Boston rheumatology meeting showed a home exercise regimen improved leg strength by 71 percent and reduced arthritic knee pain by 36 percent.
Exercise especially gentle and progressive resistance exercise that strengthens leg muscles is getting increased attention among arthritis researchers.
Harvard Medical School is about to begin a fellowship program to train internists in how to conduct research on alternative therapies.
Merck won a slight marketing edge Friday as the FDA approved Vioxx for menstrual
